Drug or chemical induced diabetes mellitus with ketoacidosis with coma
ICD-10 E09.11 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with ketoacidosis with coma.
E09.11 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of ketoacidosis and coma. This condition arises when certain medications or substances, such as glucocorticoids, antipsychotics, or other agents, disrupt normal glucose metabolism, leading to hyperglycemia and subsequent ketoacidosis. Ketoacidosis is a serious complication of diabetes, marked by the accumulation of ketones in the blood due to insufficient insulin levels. The presence of coma indicates a severe state of metabolic derangement, requiring immediate medical intervention. Management typically involves the administration of insulin, fluid replacement, and electrolyte monitoring. The condition can be life-threatening if not promptly addressed, highlighting the importance of recognizing drug-induced diabetes and its complications in clinical practice.
Detailed medication history, lab results indicating hyperglycemia and ketones, and clinical notes on the patient's response to treatment.
Patients presenting with hyperglycemia after starting new medications, particularly corticosteroids or antipsychotics.
Endocrinologists must ensure that the cause of diabetes is clearly documented to support the use of E09.11.
Immediate assessment notes, lab results, and treatment protocols followed during the acute episode.
Patients arriving in a coma due to severe ketoacidosis after drug exposure.
Emergency physicians should document the timeline of drug exposure and onset of symptoms to support coding.
Used when a patient presents with severe ketoacidosis and requires immediate intervention.
Detailed notes on the patient's condition, treatment provided, and response to care.
Emergency physicians should document the cause of the diabetes clearly.
Several classes of medications can induce diabetes, including glucocorticoids, antipsychotics, and certain immunosuppressants. It is crucial to document the specific drug involved in the patient's case.
